John Valliant wins Life Science Company of the Year Award
![Feature image Valliant 1](https://chemistry.mcmaster.ca/app/uploads/2023/03/Valliant_1.jpg)
A McMaster spin-off company won the Life Sciences Company of the Year award. Fusion’s CEO, John Valliant, Canada Research Chair in Medical Isotopes and Molecular Imaging Probes, and Professor, Chemistry &Chemical Biology, accepted the Life Sciences Company of the Year award presented by Life Sciences Ontario at a gala event honouring leaders in the province’s life sciences sector. Read more about it here in The Daily News.
Related News
News Listing
![Image of Vassili Kanellis](https://chemistry.mcmaster.ca/app/uploads/2024/04/vassili-e1713486674605.jpg)
April 17, 2024
![Photo of Professor Gary J. Schrobilgen in front of a period table of elements display](https://chemistry.mcmaster.ca/app/uploads/2024/04/Gary_J_Schrobilgen_Photo_2024.png)
La Fondation de la Maison de la Chimie ➚
Prof. Schrobilgen Awarded 2024 International Henri Moissan Prize
Uncategorized
April 1, 2024
![John Valliant with Fusion Pharmaceuticals banner](https://chemistry.mcmaster.ca/app/uploads/2023/05/Fusion.png)
McMaster Daily News ➚
AstraZeneca moves to acquire Dr. Valliant founded Fusion Pharmaceuticals for $2.4 billion (US)
Uncategorized
March 21, 2024